University of California System (US)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
199
Publications
2077
Citations
167015
i10-index
953
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Infliximab for Induction and Maintenance Therapy f... | 2005 | 3916 |
Infliximab, Azathioprine, or Combination Therapy f... | 2010 | 3147 |
Vedolizumab as Induction and Maintenance Therapy f... | 2013 | 2889 |
STRIDE-II: An Update on the Selecting Therapeutic ... | 2021 | 2870 |
Vedolizumab as Induction and Maintenance Therapy f... | 2013 | 2720 |
Adalimumab for Maintenance of Clinical Response an... | 2006 | 2252 |
Crohn's disease | 2012 | 2155 |
Ulcerative colitis | 2012 | 2088 |
Inflammatory bowel disease: clinical aspects and e... | 2007 | 1925 |
Ustekinumab as Induction and Maintenance Therapy f... | 2016 | 1849 |
William J. Sandborn is a researcher with 2077 publications and 167015 citations. They are affiliated with University of California System. Their research focuses on . With an h-index of 199, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from William J. Sandborn and 250M+ other papers.
Citations per publication by year